Turn Therapeutics Inc. Common Stock (TTRX)

Price$6.33

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)75.95%

Price vs S&P 500 (4W)31.87%

VGM Score78.86

Market Capitalization$154.90M

All Metrics

Book Value / Share (Quarterly)$0.21

P/TBV (Annual)30.82x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.15

Price vs S&P 500 (YTD)21.05%

EPS (TTM)$-0.13

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$-0.13

EPS (Annual)$-0.06

ROI (Annual)-2672.58%

Cash / Share (Quarterly)$0.38

ROA (Last FY)-86.31%

EBITD / Share (TTM)$-0.24

Cash Flow / Share (Annual)$-0.09

P/B Ratio25.32x

P/B Ratio (Quarterly)15.58x

Net Interest Coverage (TTM)-49.20x

ROA (TTM)-38.91%

EPS Incl Extra (Annual)$-0.06

Current Ratio (Annual)0.87x

Quick Ratio (Quarterly)2.19x

3-Month Avg Trading Volume0.03M

Tangible BV / Share (Quarterly)$0.17

52-Week High$26.50

EPS Excl Extra (Annual)$-0.06

26-Week Price Return91.88%

Quick Ratio (Annual)0.85x

13-Week Price Return35.42%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.23x

Enterprise Value$149.62M

Cash / Share (Annual)$0.17

3-Month Return Std Dev65.44%

ROE (Last FY)-2672.58%

EPS Basic Excl Extra (Annual)$-0.06

Total Debt / Equity (Quarterly)0.97x

EPS Incl Extra (TTM)$-0.13

ROI (TTM)-80.69%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.13

Year-to-Date Return31.98%

5-Day Price Return1.36%

EPS Normalized (Annual)$-0.06

Month-to-Date Return40.91%

EBITD / Share (Annual)$-0.06

LT Debt / Equity (Quarterly)0.97x

EPS Basic Excl Extra (TTM)$-0.13

P/TBV (Quarterly)18.34x

P/B Ratio (Annual)24.75x

Book Value / Share (Annual)$0.16

Price vs S&P 500 (13W)25.67%

Beta0.14x

Revenue / Share (TTM)$0.00

ROE (TTM)-117.30%

52-Week Low$2.57

mGradeB

vgmGradeB

Show chart for

Earnings Surprise History

Q1 26-0.03est. -0.03

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.13

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
TTRXTurn Therapeutics Inc. Common Stock	—	—	B	$6.33
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
ABTAbbott Laboratories	C	C	D	$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Turn Therapeutics is a clinical-stage biotechnology company developing treatments for dermatology, wound care, and infectious diseases. The company's proprietary PermaFusion platform enhances drug stability and bioavailability, enabling lower doses and reduced side effects. Its lead programs target moderate to severe eczema and onychomycosis.